{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":4,"total":192,"mapped":4},"pagination":{"has_next":true,"next_token":"-1[]P00441,1,P00441,129,0]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P00441","source":"P00441|Superoxide dismutase [Cu-Zn]","targets":["1AZV|FAMILIAL ALS MUTANT G37R CUZNSOD (HUMAN)|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE","1BA9|THE SOLUTION STRUCTURE OF REDUCED MONOMERIC SUPEROXIDE DISMUTASE, NMR, 36 STRUCTURES|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","1DSW|THE SOLUTION STRUCTURE OF A MONOMERIC, REDUCED FORM OF HUMAN COPPER, ZINC SUPEROXIDE DISMUTASE BEARING THE SAME CHARGE AS THE NATIVE PROTEIN|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","1FUN|SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S)|X-RAY DIFFRACTION|2.85|Homo sapiens|0|OXIDOREDUCTASE","1HL4|The Structure of Apo Type Human Cu, Zn Superoxide Dismutase|X-RAY DIFFRACTION|1.82|HOMO SAPIENS|0|OXIDOREDUCTASE","1HL5|The Structure of Holo Type Human Cu, Zn Superoxide Dismutase|X-RAY DIFFRACTION|1.8|HOMO SAPIENS|0|OXIDOREDUCTASE","1KMG|The Solution Structure Of Monomeric Copper-free Superoxide Dismutase|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","1L3N|The Solution Structure of Reduced Dimeric Copper Zinc SOD: the Structural Effects of Dimerization|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","1MFM|MONOMERIC HUMAN SOD MUTANT F50E/G51E/E133Q AT ATOMIC RESOLUTION|X-RAY DIFFRACTION|1.02|Homo sapiens|0|OXIDOREDUCTASE","1N18|Thermostable mutant of Human Superoxide Dismutase, C6A, C111S|X-RAY DIFFRACTION|2|Homo sapiens|0|OXIDOREDUCTASE","1N19|Structure of the HSOD A4V mutant|X-RAY DIFFRACTION|1.86|Homo sapiens|0|OXIDOREDUCTASE","1OEZ|Zn His46Arg mutant of Human Cu, Zn Superoxide Dismutase|X-RAY DIFFRACTION|2.15|HOMO SAPIENS|0|OXIDOREDUCTASE","1OZT|Crystal Structure of apo-H46R Familial ALS Mutant human Cu,Zn Superoxide Dismutase (CuZnSOD) to 2.5A resolution|X-RAY DIFFRACTION|2.5|Homo sapiens|0|OXIDOREDUCTASE","1OZU|Crystal Structure of Familial ALS Mutant S134N of human Cu,Zn Superoxide Dismutase (CuZnSOD) to 1.3A resolution|X-RAY DIFFRACTION|1.3|Homo sapiens|0|OXIDOREDUCTASE","1P1V|Crystal Structure of FALS-associated human Copper-Zinc Superoxide Dismutase (CuZnSOD) Mutant D125H to 1.4A|X-RAY DIFFRACTION|1.4|Homo sapiens|0|OXIDOREDUCTASE","1PTZ|Crystal structure of the human CU, Zn Superoxide Dismutase, Familial Amyotrophic Lateral Sclerosis (FALS) Mutant H43R|X-RAY DIFFRACTION|1.8|Homo sapiens|0|OXIDOREDUCTASE","1PU0|Structure of Human Cu,Zn Superoxide Dismutase|X-RAY DIFFRACTION|1.7|Homo sapiens|0|OXIDOREDUCTASE","1RK7|Solution structure of apo Cu,Zn Superoxide Dismutase: role of metal ions in protein folding|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","1SOS|ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE|X-RAY DIFFRACTION|2.5|Homo sapiens|0|OXIDOREDUCTASE (SUPEROXIDE ACCEPTOR)","1SPD|AMYOTROPHIC LATERAL SCLEROSIS AND STRUCTURAL DEFECTS IN CU,ZN SUPEROXIDE DISMUTASE|X-RAY DIFFRACTION|2.4|Homo sapiens|0|OXIDOREDUCTASE","1UXL|I113T mutant of human SOD1|X-RAY DIFFRACTION|1.6|HOMO SAPIENS|0|OXIDOREDUCTASE","1UXM|A4V mutant of human SOD1|X-RAY DIFFRACTION|1.9|HOMO SAPIENS|0|OXIDOREDUCTASE","2AF2|Solution structure of disulfide reduced and copper depleted Human Superoxide Dismutase|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","2C9S|1.24 Angstroms resolution structure of Zn-Zn Human Superoxide dismutase|X-RAY DIFFRACTION|1.24|HOMO SAPIENS|0|OXIDOREDUCTASE","2C9U|1.24 Angstroms resolution structure of as-isolated Cu-Zn Human Superoxide dismutase|X-RAY DIFFRACTION|1.24|HOMO SAPIENS|0|OXIDOREDUCTASE","2C9V|Atomic resolution structure of Cu-Zn Human Superoxide dismutase|X-RAY DIFFRACTION|1.07|HOMO SAPIENS|0|OXIDOREDUCTASE","2GBT|C6A/C111A CuZn Superoxide dismutase|X-RAY DIFFRACTION|1.7|Homo sapiens|0|OXIDOREDUCTASE","2GBU|C6A/C111A/C57A/C146A apo CuZn Superoxide dismutase|X-RAY DIFFRACTION|2|Homo sapiens|0|OXIDOREDUCTASE","2GBV|C6A/C111A/C57A/C146A holo CuZn Superoxide dismutase|X-RAY DIFFRACTION|2|Homo sapiens|0|OXIDOREDUCTASE","2LU5|Structure and chemical shifts of Cu(I),Zn(II) superoxide dismutase by solid-state NMR|SOLID-STATE NMR||Homo sapiens|0|OXIDOREDUCTASE","2MP3|Truncated L126Z-sod1 in DPC micelle|SOLUTION NMR||Homo sapiens|0|OXIDOREDUCTASE","2NAM|Full-length WT SOD1 in DPC MICELLE|SOLUTION NMR||Homo sapiens|0|METAL BINDING PROTEIN","2NNX|Crystal Structure of the H46R, H48Q double mutant of human [Cu-Zn] Superoxide Dismutase|X-RAY DIFFRACTION|2.3|Homo sapiens|0|OXIDOREDUCTASE","2R27|Constitutively zinc-deficient mutant of human superoxide dismutase (SOD), C6A, H80S, H83S, C111S|X-RAY DIFFRACTION|2|Homo sapiens|0|OXIDOREDUCTASE","2V0A|Atomic resolution crystal structure of Human Superoxide Dismutase|X-RAY DIFFRACTION|1.15|HOMO SAPIENS|0|OXIDOREDUCTASE","2VR6|Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.3 A resolution|X-RAY DIFFRACTION|1.3|HOMO SAPIENS|0|OXIDOREDUCTASE","2VR7|Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.58 A resolution|X-RAY DIFFRACTION|1.58|HOMO SAPIENS|0|OXIDOREDUCTASE","2VR8|Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at 1.36 A resolution|X-RAY DIFFRACTION|1.36|HOMO SAPIENS|0|OXIDOREDUCTASE","2WKO|Structure of metal loaded Pathogenic SOD1 Mutant G93A.|X-RAY DIFFRACTION|1.97|HOMO SAPIENS|0|OXIDOREDUCTASE","2WYT|1.0 A resolution structure of L38V SOD1 mutant|X-RAY DIFFRACTION|1|HOMO SAPIENS|0|OXIDOREDUCTASE","2WYZ|L38V SOD1 mutant complexed with UMP|X-RAY DIFFRACTION|1.7|HOMO SAPIENS|0|OXIDOREDUCTASE","2WZ0|L38V SOD1 mutant complexed with aniline.|X-RAY DIFFRACTION|1.72|HOMO SAPIENS|0|OXIDOREDUCTASE","2WZ5|L38V SOD1 mutant complexed with L-methionine.|X-RAY DIFFRACTION|1.5|HOMO SAPIENS|0|OXIDOREDUCTASE","2WZ6|G93A SOD1 mutant complexed with Quinazoline.|X-RAY DIFFRACTION|1.55|HOMO SAPIENS|0|OXIDOREDUCTASE","2XJK|Monomeric Human Cu,Zn Superoxide dismutase|X-RAY DIFFRACTION|1.45|HOMO SAPIENS|0|OXIDOREDUCTASE","2XJL|Monomeric Human Cu,Zn Superoxide dismutase without Cu ligands|X-RAY DIFFRACTION|1.55|HOMO SAPIENS|0|OXIDOREDUCTASE","2ZKW|Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group P21|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE","2ZKX|Crystal structure of human Cu-Zn superoxide dismutase mutant G85R in space group I212121|X-RAY DIFFRACTION|2.72|Homo sapiens|0|OXIDOREDUCTASE","2ZKY|Crystal structure of human Cu-Zn superoxide dismutase mutant G93A|X-RAY DIFFRACTION|2.4|Homo sapiens|0|OXIDOREDUCTASE","3CQP|Human SOD1 G85R Variant, Structure I|X-RAY DIFFRACTION|1.95|Homo sapiens|0|OXIDOREDUCTASE","3CQQ|Human SOD1 G85R Variant, Structure II|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE","3ECU|Crystal structure of human apo Cu,Zn Superoxide Dismutase (SOD1)|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE","3ECV|Crystal structure of the ALS-related pathological mutant I113T of human apo Cu,Zn Superoxide Dismutase (SOD1)|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE","3ECW|Crystal structure of the ALS-related pathological mutant T54R of human apo Cu,Zn Superoxide Dismutase (SOD1)|X-RAY DIFFRACTION|2.15|Homo sapiens|0|OXIDOREDUCTASE","3GQF|Structural and Biophysical Properties of the Pathogenic SOD1 Variant H46R/H48Q|X-RAY DIFFRACTION|2.2|Homo sapiens|0|OXIDOREDUCTASE","3GTV|Human-mouse SOD1 chimera|X-RAY DIFFRACTION|2.2|Homo sapiens; Mus musculus|0|OXIDOREDUCTASE","3GZO|HUMAN SOD1 G93A Variant|X-RAY DIFFRACTION|2.1|Homo sapiens|0|OXIDOREDUCTASE","3GZP|HUMAN SOD1 G93A Metal-free Variant|X-RAY DIFFRACTION|3.1|Homo sapiens|0|OXIDOREDUCTASE","3GZQ|HUMAN SOD1 A4V Metal-free Variant|X-RAY DIFFRACTION|1.401|Homo sapiens|0|OXIDOREDUCTASE","3H2P|Human SOD1 D124V Variant|X-RAY DIFFRACTION|1.55|Homo sapiens|0|OXIDOREDUCTASE","3H2Q|Human SOD1 H80R variant, P21 crystal form|X-RAY DIFFRACTION|1.85|Homo sapiens|0|OXIDOREDUCTASE","3HFF|Monomeric human Cu,Zn Superoxide dismutase without Zn ligands|X-RAY DIFFRACTION|2.2|Homo sapiens|0|OXIDOREDUCTASE","3K91|Polysulfane Bridge in Cu-Zn Superoxide Dismutase|X-RAY DIFFRACTION|1.75|Homo sapiens|0|OXIDOREDUCTASE","3KH3|Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P212121 crystal form containing 12 chains in the asymmetric unit|X-RAY DIFFRACTION|3.5|Homo sapiens|0|OXIDOREDUCTASE","3KH4|Crystal structure of human Cu/Zn superoxide dismutase recombinantly produced in Leishmania tarantolae; P6522 crystal form containing 6 chains in the asymmetric unit|X-RAY DIFFRACTION|3.5|Homo sapiens|0|OXIDOREDUCTASE","3LTV|Mouse-human sod1 chimera|X-RAY DIFFRACTION|2.453|Homo sapiens; Mus musculus|0|OXIDOREDUCTASE","3QQD|Human SOD1 H80R variant, P212121 crystal form|X-RAY DIFFRACTION|1.653|Homo sapiens|0|OXIDOREDUCTASE","3RE0|Crystal structure of human apo Cu,Zn superoxide dismutase (SOD1) complexed with cisplatin|X-RAY DIFFRACTION|2.28|Homo sapiens|0|OXIDOREDUCTASE","3T5W|2ME modified human SOD1|X-RAY DIFFRACTION|1.8|Homo sapiens|0|OXIDOREDUCTASE","4A7G|Structure of human I113T SOD1 mutant complexed with 4-methylpiperazin- 1-yl)quinazoline in the p21 space group.|X-RAY DIFFRACTION|1.24|HOMO SAPIENS|0|OXIDOREDUCTASE","4A7Q|Structure of human I113T SOD1 mutant complexed with 4-(4-methyl-1,4- diazepan-1-yl)quinazoline in the p21 space group.|X-RAY DIFFRACTION|1.22|HOMO SAPIENS|0|OXIDOREDUCTASE","4A7S|Structure of human I113T SOD1 mutant complexed with 5-Fluorouridine in the p21 space group|X-RAY DIFFRACTION|1.06|HOMO SAPIENS|0|OXIDOREDUCTASE","4A7T|Structure of human I113T SOD1 mutant complexed with isoproteranol in the p21 space group|X-RAY DIFFRACTION|1.45|HOMO SAPIENS|0|OXIDOREDUCTASE","4A7U|Structure of human I113T SOD1 complexed with adrenaline in the p21 space group.|X-RAY DIFFRACTION|0.98|HOMO SAPIENS|0|OXIDOREDUCTASE","4A7V|Structure of human I113T SOD1 mutant complexed with dopamine in the p21 space group|X-RAY DIFFRACTION|1|HOMO SAPIENS|0|OXIDOREDUCTASE","4B3E|Structure of copper-zinc superoxide dismutase complexed with bicarbonate.|X-RAY DIFFRACTION|2.15|HOMO SAPIENS|0|OXIDOREDUCTASE","4BCY|Monomeric Human Cu,Zn Superoxide dismutase, mutation H43F|X-RAY DIFFRACTION|1.272|HOMO SAPIENS|0|OXIDOREDUCTASE","4BCZ|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form.|X-RAY DIFFRACTION|1.93|HOMO SAPIENS|0|OXIDOREDUCTASE","4BD4|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F|X-RAY DIFFRACTION|2.78|HOMO SAPIENS|0|OXIDOREDUCTASE","4FF9|Crystal Structure of cysteinylated WT SOD1.|X-RAY DIFFRACTION|2.5003|Homo sapiens|0|OXIDOREDUCTASE","4MCM|Human SOD1 C57S Mutant, As-isolated|X-RAY DIFFRACTION|2.2|Homo sapiens|0|OXIDOREDUCTASE","4MCN|Human SOD1 C57S Mutant, Metal-free|X-RAY DIFFRACTION|2.6|Homo sapiens|0|OXIDOREDUCTASE","4NIN|DSVISLS segment 101-107 from Human Superoxide Dismutase|X-RAY DIFFRACTION|1.402||0|PROTEIN FIBRIL","4NIO|GVTGIAQ segment 147-153 from Human Superoxide Dismutase with I149T mutation associated with a familial form of amyotrophic lateral sclerosis|X-RAY DIFFRACTION|1.3||0|PROTEIN FIBRIL","4NIP|GVIGIAQ segment 147-153 from Human Superoxide Dismutase|X-RAY DIFFRACTION|1.9||0|PROTEIN FIBRIL","4OH2|Crystal Structure of Cu/Zn Superoxide Dismutase I149T|X-RAY DIFFRACTION|2.384|Homo sapiens|0|OXIDOREDUCTASE","4XCR|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant I35A|X-RAY DIFFRACTION|3.602|Homo sapiens|0|OXIDOREDUCTASE","5DLI|Corkscrew assembly of SOD1 residues 28-38|X-RAY DIFFRACTION|2.1||0|UNKNOWN FUNCTION","5IIW|Corkscrew assembly of SOD1 residues 28-38 without potassium iodide|X-RAY DIFFRACTION|2||0|UNKNOWN FUNCTION","5J07|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P1/2|X-RAY DIFFRACTION|2|Homo sapiens|0|OXIDOREDUCTASE","5J0C|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P2/3|X-RAY DIFFRACTION|1.6|Homo sapiens|0|OXIDOREDUCTASE","5J0F|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P4/5|X-RAY DIFFRACTION|1.25|Homo sapiens|0|OXIDOREDUCTASE","5J0G|Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, circular permutant P7/8|X-RAY DIFFRACTION|2.5|Homo sapiens|0|OXIDOREDUCTASE","5K02|Structure of human SOD1 with T2D mutation|X-RAY DIFFRACTION|1.99|Homo sapiens|0|OXIDOREDUCTASE","5O3Y|SOD1 bound to Ebsulfur|X-RAY DIFFRACTION|1.3|Homo sapiens|0|OXIDOREDUCTASE","5O40|SOD1 bound to Ebselen|X-RAY DIFFRACTION|1.5|Homo sapiens|0|OXIDOREDUCTASE","5U9M|Copper-Zinc Superoxide Dismutase is Activated through a Sulfenic Acid Intermediate at a Copper-ion Entry Site|X-RAY DIFFRACTION|2.35|Homo sapiens; Saccharomyces cerevisiae (strain ATCC 204508 / S288c)|0|oxidoreductase/chaperone","5WMJ|KVWGSI segment from Superoxide Dismutase 1,residues 30-35|X-RAY DIFFRACTION|1.4||0|PROTEIN FIBRIL","5WOR|Corkscrew assembly of SOD1 residues 28-38 with familial mutation G37R|X-RAY DIFFRACTION|2.77||0|PROTEIN FIBRIL","5YTO|Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound.|X-RAY DIFFRACTION|1.9|Homo sapiens|0|OXIDOREDUCTASE"]},{"input":"Q9UHD2","source":"Q9UHD2|Serine/threonine-protein kinase TBK1","targets":["4EFO|Crystal structure of the ubiquitin-like domain of human TBK1|X-RAY DIFFRACTION|1.769|Homo sapiens|0|TRANSFERASE","4EUT|Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4EUU|Structure of BX-795 Complexed with Human TBK1 Kinase Domain Phosphorylated on Ser172|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IM0|Structure of Tank-Binding Kinase 1|X-RAY DIFFRACTION|2.4001|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IM2|Structure of Tank-Binding Kinase 1|X-RAY DIFFRACTION|2.5001|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IM3|Structure of Tank-Binding Kinase 1|X-RAY DIFFRACTION|3.342|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IW0|Crystal structure and mechanism of activation of TBK1|X-RAY DIFFRACTION|4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IWO|Crystal structure and mechanism of activation of TBK1|X-RAY DIFFRACTION|2.61|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IWP|Crystal structure and mechanism of activation of TBK1|X-RAY DIFFRACTION|3.065|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IWQ|Crystal structure and mechanism of activation of TBK1|X-RAY DIFFRACTION|3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5EOA|Crystal structure of OPTN E50K mutant and TBK1 complex|X-RAY DIFFRACTION|2.503|Homo sapiens|0|PROTEIN BINDING/TRANSFERASE","5EOF|Crystal structure of OPTN NTD and TBK1 CTD complex|X-RAY DIFFRACTION|2.05|Homo sapiens|0|PROTEIN BINDING/TRANSFERASE","5EP6|The crystal structure of NAP1 in complex with TBK1|X-RAY DIFFRACTION|1.451|Homo sapiens|0|PROTEIN BINDING/TRANSFERASE","5W5V|TBK1 co-crystal structure with amlexanox|X-RAY DIFFRACTION|3.645|Homo sapiens|0|TRANSFERASE","6BNY|TBK1 in complex with tetrazole analog of amlexanox|X-RAY DIFFRACTION|3.341|Homo sapiens|0|TRANSFERASE/INHIBITOR","6BOD|TBK1 in complex with ethyl ester analog of amlexanox|X-RAY DIFFRACTION|3.197|Homo sapiens|0|TRANSFERASE","6BOE|TBK1 in complex with amide-coupled tetrazole analog of amlexanox|X-RAY DIFFRACTION|3.598|Homo sapiens|0|TRANSFERASE","6CQ0|TBK1 in Complex with Dimethyl Amino Analog of Amlexanox|X-RAY DIFFRACTION|3.19|Homo sapiens|0|TRANSFERASE","6CQ4|TBK1 in Complex with Cyclohexyl Analog of Amlexanox|X-RAY DIFFRACTION|3.2|Homo sapiens|0|TRANSFERASE","6CQ5|TBK1 in Complex with Sulfone Analog of Amlexanox|X-RAY DIFFRACTION|3.354|Homo sapiens|0|TRANSFERASE","6NT9|Cryo-EM structure of the complex between human TBK1 and chicken STING|ELECTRON MICROSCOPY|3.3|Gallus gallus; Homo sapiens|0|IMMUNE SYSTEM","6O8B|Crystal structure of STING CTD in complex with TBK1|X-RAY DIFFRACTION|3.4|Homo sapiens|0|IMMUNE SYSTEM","6RSR|TBK1 in complex with compound 2|X-RAY DIFFRACTION|3.15|Homo sapiens|0|IMMUNE SYSTEM","6RST|TBK1 in complex with inhibitor compound 24|X-RAY DIFFRACTION|3.29|Homo sapiens|0|IMMUNE SYSTEM","6RSU|TBK1 in complex with Inhibitor compound 35|X-RAY DIFFRACTION|2.75|Homo sapiens|0|IMMUNE SYSTEM"]},{"input":"P35637","source":"P35637|RNA-binding protein FUS","targets":["2LA6|Solution NMR Structure of RRM domain of RNA-binding protein FUS from homo sapiens, Northeast Structural Genomics Consortium Target HR6430A|SOLUTION NMR||Homo sapiens|0|RNA BINDING PROTEIN","2LCW|solution structure of FUS/TLS RRM domain|SOLUTION NMR||Homo sapiens|0|RNA BINDING PROTEIN","4FDD|Crystal structure of KAP beta2-PY-NLS|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSPORT PROTEIN","4FQ3|Crystal structure of transportin/FUS-NLS|X-RAY DIFFRACTION|3|Homo sapiens|0|PROTEIN BINDING","5W3N|Molecular structure of FUS low sequence complexity domain protein fibrils|SOLID-STATE NMR||Homo sapiens|0|PROTEIN FIBRIL","5XRR|Crystal structure of FUS (54-59) SYSSYG|X-RAY DIFFRACTION|1.503||0|RNA BINDING PROTEIN","5XSG|Ultrahigh resolution structure of FUS (37-42) SYSGYS determined by MicroED|ELECTRON CRYSTALLOGRAPHY|0.73||0|RNA BINDING PROTEIN","5YVG|Crystal structure of Karyopherin beta2 in complex with FUS(full length)|X-RAY DIFFRACTION|4.05|Homo sapiens|0|PROTEIN TRANSPORT/RNA BINDING PROTEIN","5YVH|Crystal structure of Karyopherin beta2 in complex with FUS(371-526)|X-RAY DIFFRACTION|3.15|Homo sapiens|0|PROTEIN TRANSPORT/RNA BINDING PROTEIN","5YVI|Crystal structure of Karyopherin beta2 in complex with FUS(456-526)|X-RAY DIFFRACTION|2.9|Homo sapiens|0|PROTEIN TRANSPORT/RNA BINDING PROTEIN","6BWZ|SYSGYS from low-complexity domain of FUS, residues 37-42|X-RAY DIFFRACTION|1.1||0|PROTEIN FIBRIL","6BXV|SYSSYGQS from low-complexity domain of FUS, residues 54-61|X-RAY DIFFRACTION|1.1||0|PROTEIN FIBRIL","6BZP|STGGYG from low-complexity domain of FUS, residues 77-82|ELECTRON CRYSTALLOGRAPHY|1.1||0|PROTEIN FIBRIL","6G99|Solution structure of FUS-ZnF bound to UGGUG|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|RNA BINDING PROTEIN","6GBM|Solution structure of FUS-RRM bound to stem-loop RNA|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|RNA BINDING PROTEIN","6KJ1|200kV MicroED structure of FUS (37-42) SYSGYS solved from merged datasets at 0.65 A|ELECTRON CRYSTALLOGRAPHY|0.65||0|RNA BINDING PROTEIN","6KJ2|200kV MicroED structure of FUS (37-42) SYSGYS solved from single crystal at 0.67 A|ELECTRON CRYSTALLOGRAPHY|0.67||0|RNA BINDING PROTEIN","6KJ3|120kV MicroED structure of FUS (37-42) SYSGYS solved from merged datasets at 0.60 A|ELECTRON CRYSTALLOGRAPHY|0.6||0|RNA BINDING PROTEIN","6KJ4|120kV MicroED structure of FUS (37-42) SYSGYS solved from single crystal at 0.65 A|ELECTRON CRYSTALLOGRAPHY|0.65||0|RNA BINDING PROTEIN","6SNJ|Solution structure of the FUS/TLS RNA recognition motif in complex with U1 snRNA stem loop III|SOLUTION NMR||Homo sapiens|0|SPLICING","6XFM|Molecular structure of the core of amyloid-like fibrils formed by residues 111-214 of FUS|ELECTRON MICROSCOPY|2.62|Homo sapiens|0|RNA BINDING PROTEIN, PROTEIN FIBRIL","7CYL|Crystal structure of Karyopherin-beta2 in complex with FUS PY-NLS(P525L)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSPORT PROTEIN/RNA BINDING PROTEIN","7VQQ|Cryo-EM structure of amyloid fibril formed by FUS low complexity domain|ELECTRON MICROSCOPY|2.9|Aequorea victoria; Homo sapiens|0|PROTEIN FIBRIL"]},{"input":"Q13148","source":"Q13148|TAR DNA-binding protein 43","targets":["1WF0|Solution structure of RRM domain in TAR DNA-binding protein-43|SOLUTION NMR||Homo sapiens|0|RNA BINDING PROTEIN","2CQG|Solution structure of the RNA binding domain of TAR DNA-binding protein-43|SOLUTION NMR||Homo sapiens|0|RNA BINDING PROTEIN","2N2C|NMR Structure of TDP-43 prion-like hydrophobic helix in DPC|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","2N3X|Solution Structure of TDP-43 Amyloidogenic Core Region|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","2N4G|Solution Structure of the G335D Mutant of TDP-43 Amyloidogenic Core Region|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","2N4H|Solution Structure of the Q343R Mutant of TDP-43 Amyloidogenic Core Region|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","2N4P|Solution structure of the n-terminal domain of tdp-43|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","4BS2|NMR structure of human TDP-43 tandem RRMs in complex with UG-rich RNA|SOLUTION NMR||HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","4IUF|Crystal Structure of Human TDP-43 RRM1 Domain in Complex with a Single-stranded DNA|X-RAY DIFFRACTION|2.752|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION REGULATOR/DNA","4Y00|Crystal Structure of Human TDP-43 RRM1 Domain with D169G Mutation in Complex with an Unmodified Single-stranded DNA|X-RAY DIFFRACTION|3|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","4Y0F|Crystal Structure of Human TDP-43 RRM1 Domain in Complex with an Unmodified Single-stranded DNA|X-RAY DIFFRACTION|2.648|Homo sapiens; SYNTHETIC CONSTRUCT|0|DNA BINDING PROTEIN/DNA","5MDI|Crystal structure of TDP-43 N-terminal domain at 2.1 A resolution|X-RAY DIFFRACTION|2.1|Homo sapiens|0|RNA BINDING PROTEIN","5MRG|Solution structure of TDP-43 (residues 1-102)|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","5W50|Crystal structure of the segment, LIIKGI, from the RRM2 of TDP-43, residues 248-253|X-RAY DIFFRACTION|1.4||0|PROTEIN FIBRIL","5W52|MicroED structure of the segment, DLIIKGISVHI, from the RRM2 of TDP-43, residues 247-257|ELECTRON CRYSTALLOGRAPHY|1.4||0|PROTEIN FIBRIL","5W7V|CryoEM structure of the segment, DLIIKGISVHI, assembled into a triple-helical fibril|ELECTRON MICROSCOPY|3.8||0|PROTEIN FIBRIL","5WHN|Crystal structure of the segment, NFGAFS, from the low complexity domain of TDP-43, residues 312-317|X-RAY DIFFRACTION|1.1||0|PROTEIN FIBRIL","5WHP|Crystal structure of the segment, NFGTFS, from the A315T familial variant of the low complexity domain of TDP-43, residues 312-317|X-RAY DIFFRACTION|1||0|PROTEIN FIBRIL","5WIA|Crystal structure of the segment, GNNSYS, from the low complexity domain of TDP-43, residues 370-375|X-RAY DIFFRACTION|1.002||0|PROTEIN FIBRIL","5WIQ|Crystal structure of the segment, GFNGGFG, from the low complexity domain of TDP-43, residues 396-402|X-RAY DIFFRACTION|1.25||0|PROTEIN FIBRIL","5WKB|MicroED structure of the segment, NFGEFS, from the A315E familial variant of the low complexity domain of TDP-43, residues 312-317|ELECTRON CRYSTALLOGRAPHY|1.0||0|PROTEIN FIBRIL","5WKD|Crystal structure of the segment, GNNQGSN, from the low complexity domain of TDP-43, residues 300-306|X-RAY DIFFRACTION|1.8||0|PROTEIN FIBRIL","5X4F|Solution Structure of the N-terminal Domain of TDP-43|SOLUTION NMR||Homo sapiens|0|DNA BINDING PROTEIN","6B1G|Solution structure of TDP-43 N-terminal domain dimer.|SOLUTION NMR||Homo sapiens|0|STRUCTURAL PROTEIN","6CF4|Segment NFGTFS, with familial mutation A315T and phosphorylated threonine, from the low complexity domain of TDP-43, residues 312-317|ELECTRON CRYSTALLOGRAPHY|0.75||0|PROTEIN FIBRIL","6CFH|SWGMMGMLASQ segment from the low complexity domain of TDP-43|ELECTRON CRYSTALLOGRAPHY|1.5||0|PROTEIN FIBRIL","6N37|SegA-sym, conformation of TDP-43 low complexity domain segment A sym|ELECTRON MICROSCOPY|3.8|Homo sapiens|0|PROTEIN FIBRIL","6N3A|SegA-long, conformation of TDP-43 low complexity domain segment A long|ELECTRON MICROSCOPY|3.3|Homo sapiens|0|dna binding protein, protein fibril","6N3B|SegA-asym, conformation of TDP-43 low complexity domain segment A asym|ELECTRON MICROSCOPY|3.8|Homo sapiens|0|dna binding protein, protein fibril","6N3C|SegB, conformation of TDP-43 low complexity domain segment A|ELECTRON MICROSCOPY|3.3|Homo sapiens|0|dna binding protein, protein fibril","6T4B|CRYSTAL STRUCTURE OF HUMAN TDP-43 N-TERMINAL DOMAIN AT 2.55 A RESOLUTION|X-RAY DIFFRACTION|2.55|Homo sapiens|0|DNA BINDING PROTEIN","7KWZ|TDP-43 LCD amyloid fibrils|ELECTRON MICROSCOPY|3.2|Homo sapiens|0|PROTEIN FIBRIL","7N9H|Structure of the mammalian importin a1 bound to the TDP-43 NLS|X-RAY DIFFRACTION|2.2|Homo sapiens|0|PROTEIN TRANSPORT","7PY2|Structure of pathological TDP-43 filaments from ALS with FTLD|ELECTRON MICROSCOPY|2.59|Homo sapiens|0|PROTEIN FIBRIL","7Q3U|Cryo-EM structure of TDP43 core peptide amyloid fiber|ELECTRON MICROSCOPY|3.7|Homo sapiens|0|RNA BINDING PROTEIN","8A6I|Structure of the low complexity domain of TDP-43 (fragment 309-350) with methionine sulfoxide modifications|SOLUTION NMR||Homo sapiens|0|UNKNOWN FUNCTION","8CG3|Structure of TDP-43 amyloid filament from type A FTLD-TDP (variant 1)|ELECTRON MICROSCOPY|2.39|Homo sapiens|0|PROTEIN FIBRIL","8CGG|Structure of TDP-43 amyloid filament from type A FTLD-TDP (variant 2)|ELECTRON MICROSCOPY|2.5|Homo sapiens|0|RNA BINDING PROTEIN","8CGH|Structure of TDP-43 amyloid filament from type A FTLD-TDP (variant 3)|ELECTRON MICROSCOPY|2.68|Homo sapiens|0|PROTEIN FIBRIL","8QX9|TDP-43 amyloid fibrils: Morphology-1a|ELECTRON MICROSCOPY|3.76|Homo sapiens|0|PROTEIN FIBRIL","8QXA|TDP-43 amyloid fibrils: Morphology-1b|ELECTRON MICROSCOPY|4.05|Homo sapiens|0|PROTEIN FIBRIL","8QXB|TDP-43 amyloid fibrils: Morphology-2|ELECTRON MICROSCOPY|3.86|Homo sapiens|0|PROTEIN FIBRIL","9FOF|Structure of heteromeric amyloid filament of TDP-43 and AXNA11 from FTLD-TDP Type C (variant 2)|ELECTRON MICROSCOPY|2.9|Homo sapiens|0|PROTEIN FIBRIL","9FOR|Structure of heteromeric amyloid filament of TDP-43 and AXNA11 from FTLD-TDP Type C (variant 1)|ELECTRON MICROSCOPY|2.75|Homo sapiens|0|PROTEIN FIBRIL"]}]}